Research Paper Volume 15, Issue 7 pp 2734—2771
Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
Figure 7. TSEN54 is an independent prognostic factor for the survival of HCC patients. (A) The association between TSEN54 expression and HCC patients based on data downloaded from TCGA. (B) ROC curve for one-, three-, and five-year survival according to TSEN54 expression level. (C) The forest plot displays the result of the multivariate analysis. *p< 0.05; **p< 0.01; ***p< 0.001.